海角精品黑料

New test searches for tiniest remnants of Neal Augenstein’s lung cancer in his blood

Almost four years after revealing his Stage 4 lung cancer diagnosis, 海角精品黑料 reporter Neal Augenstein recently took a new and highly sensitive blood test that can provide valuable information to patients and their doctors.

Neal Augenstein has been a general assignment reporter with 海角精品黑料 since 1997.(海角精品黑料/Neal Augenstein)

Neal was diagnosed with lung cancer聽in November 2022. Lung cancer is by far the leading cause of cancer death in the U.S., accounting for 1 in 5 of all cancer deaths, according to .

According to the American Lung Association’s annual , the national five-year survival rate for lung cancer has increased 26% over the past five years, reaching 29.7%.

Ongoing clinical trials are evaluating the role of minimal residual disease (MRD) testing, to track whether any remnants of a patient’s tumor remain in their blood after surgery and other treatments.

Neal shared his results with 海角精品黑料 morning anchors John Aaron and Kristen Diaz Wednesday.

海角精品黑料's Neal Augenstein shares a health update with the morning anchors.

Get breaking news and daily headlines delivered to your email inbox by signing up here.

漏 2026 海角精品黑料. All Rights Reserved. This website is not intended for users located within the European Economic Area.

Federal News Network Logo
Log in to your 海角精品黑料 account for notifications and alerts customized for you.